PHINIA (PHIN) Director Rohan Weerasinghe Receives Award

What Happened

Rohan Weerasinghe, a director of PHINIA Inc. (PHIN), received equity awards on 2026-09-18 consisting of 42 DRSUs (acquired via automatic dividend reinvestment) and 26 additional derivative DRSUs, all granted at $0.00 (total reported = 68 units). These are awards/grants (Form 4 code A) — no cash was exchanged. The filing notes these DRSUs are the economic equivalent of common shares and are subject to vesting and settlement rules under the issuer’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.

Key Details

• Transaction date: 2026-09-18 (Filed: 2026-09-21).
• Type/Code: Award/Grant (A).
• Amounts/prices: 42 DRSUs @ $0.00 (dividend reinvestment per F1) and 26 derivative DRSUs @ $0.00; total 68 DRSUs; reported cash value = $0.
• Vesting/settlement: Per F3, each DRSU equals one share, vests on May 22, 2027, and will settle into shares upon the reporting person’s termination of board service. F2 notes 8,625 DRSUs have already vested and will settle upon termination.
• Shares owned after transaction: The filing does not state a full common-stock total; see F2 regarding 8,625 vested DRSUs.
• Timeliness: Filed three days after the transaction date (9/18 → 9/21); Form 4s are generally due within two business days, so this filing may be late.
• Other: Power of Attorney attached as Exhibit 24.

Context

DRSUs are deferred equity awards that convert into shares later (here, on termination of board service or after vesting), so this grant does not represent an open-market purchase or sale and does not indicate an immediate change in market exposure. Derivative entries mean the units are rights to future shares rather than current unrestricted common stock. Awards to directors are commonly used as compensation/retention and should be interpreted as such rather than a direct buy/sell signal.